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Abstract: The fat mass and obesity-associated (FTO) gene is currently recognized as  
the most robust predictor of polygenic obesity. We investigated associations between the 
FTO rs1421085 and rs17817449 polymorphisms and the FTO rs1421085–rs17817449 
haplotype and dietary intake, eating behavior, physical activity, and psychological health, 
as well as the effect of these associations on BMI. N = 133 treatment seeking 
overweight/obese Caucasian adults participated in this study. Genotyping was performed 
from whole blood samples. Weight and height was measured and a non-quantified food 
frequency questionnaire was completed to assess food group intake. Validated 
questionnaires were completed to assess physical activity (Baecke questionnaire), 
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psychological health (General Health questionnaire, Rosenburg self-esteem scale and Beck 
Depression Inventory), and eating behavior (Three Factor Eating questionnaire). The risk 
alleles of the FTO polymorphisms were associated with poorer eating behaviors (higher 
hunger, internal locus for hunger, and emotional disinhibition scores), a higher intake of 
high fat foods and refined starches and more depressive symptoms. The modeled results 
indicate that interactions between the FTO polymorphisms or haplotypes and eating 
behavior, psychological health, and physical activity levels may be associated with BMI. 
The clinical significance of these results for implementation as part of weight management 
interventions needs further investigation. 
Keywords: fat mass and obesity associated gene; FTO gene; eating behavior; depression; 
psychological well-being; dietary intake; physical activity; BMI; obesity 
 
1. Introduction 
Obesity has reached epidemic proportions and is still escalating at an alarming rate world-wide, 
affecting children and adults in both developed and developing countries [1,2]. The etiology of obesity 
is multi-factorial and any combination of environmental and lifestyle factors may interact with multiple 
genetic polymorphisms to result in the condition [3,4]. To date the fat mass and obesity-associated 
(FTO) gene stands out as the most robust and significant genetic contributor to polygenic obesity [5,6]. 
The risk alleles of several FTO polymorphisms located within a 47 kb linkage disequilibrium (LD) 
block encompassing sections of intron 1 and exon 2 of FTO have been associated with obesity and a 
higher BMI [7–9]. In genome-wide association studies the strongest associations with weight related 
phenotypes were reported for the FTO rs9939609 [8], rs9930506 [9], rs1421085, rs17817449, and 
rs1121980 [7] polymorphisms. However, the cluster of afore-mentioned polymorphisms is intronic and 
their physiological effects contributing to obesity development remain to be identified [10]. 
FTO encodes a Fe(II)- and 2-oxoglutarate (OG) dependent nucleic acid demethylase that localizes 
to the nucleus of cells [11,12]. However, the exact structure of the FTO protein [13] as well as its 
physiological function and role in obesity development still need to be elucidated [14]. The results of 
in vitro experiments point to the possibility that FTO exerts gene regulation at RNA level in humans, 
as it catalyzes the demethylation of 3-methylthymine in single-stranded DNA, 3-methyluracil in  
RNA [11,13,15] and N6-methyladenosine in nuclear RNA [16]. 
FTO is expressed in the cell nucleus of almost all human tissues [7]. The highest expression  
levels are found in the brain, specifically in the arcuate nucleus of the hypothalamus, which is known 
to play a major role in controlling energy homeostasis and eating behavior [8]. A possible role in 
energy homeostasis is supported by studies performed on humans, mice and rodents that have shown 
that Fto mRNA expression is regulated by food intake [11,17–19], circulating glucose levels [20], 
weight status [21,22] and energy expenditure [18,23]. In human and mouse cell lines, FTO expression 
is reversibly influenced by essential amino acid deprivation and replacement [24]. Furthermore, 
Pitman et al. [25] illustrated that knockdown of FTO expression increased ATP concentrations in 
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neuronal cells, but decreased ATP concentrations in adipocytes, implying a mechanism of cell-specific 
control over energy production. 
Research in mouse models shows that knockout of Fto results in normal embryonic development, 
but high postnatal lethality, growth retardation and lower weight and adiposity measures [23,26,27]. 
Similarly, adult onset Fto knockout mice also experience reduced weight and lean mass initially. 
However, thereafter their weight tended to converge with that of wild-type mice due to increases in 
body fat mass [27]. Fischer et al. [23] indicated that Fto knockout mice were protected from diet-induced 
obesity throughout their entire life span when consuming a high fat diet, while a high fat intake 
augmented weight gain in the mice with FTO overexpression [26]. Overexpression of FTO also seemed 
to be associated with higher food intakes and consequent weight and fat mass gains when expenditure 
and physical activity levels remained unchanged [26]. A number of possible but inconclusive mechanisms 
for FTO’s role in explaining these findings have been proposed. These include that FTO may influence 
protein and/or fat utilization [27], as well as energy expenditure and adrenalin levels [23,28]. 
Results from work in humans are also not yet conclusive, with some reporting a link between the risk 
alleles and increased energy expenditure [29,30], whereas others failed to show any association [31–34]. 
The risk alleles have also been associated with poorer eating behaviors [7–9], higher food, energy and 
fat intakes and specific preference for energy-dense foods with high fat content [29,32,34–37]. Although 
these studies mostly investigated the rs9939609 polymorphism, McCaffery et al. [37] suggest that  
the rs1421085 polymorphism may better illustrate the effect of the FTO locus on dietary intake and 
patterns, as the associations they found between the latter variables and the risk alleles of rs1421085 
were more consistent compared to the other FTO polymorphisms investigated (rs9939609, rs3751812, 
rs9922708). However, it needs to be noted that Stutzman et al. [38] found no association between the 
rs1421085 polymorphism and eating behavior or meal size and snacking patterns in Caucasians [38]. 
There is a paucity of information on the association between FTO rs17817449 and lifestyle related 
variables. Further research is clearly necessary to elucidate the associations of FTO polymorphisms 
with eating behavior, dietary intake, and energy expenditure. 
The objectives of this study were firstly to investigate the association between the FTO rs1421085 
and rs17817449 polymorphisms as well as the FTO rs1421085-rs17817449 haplotype and dietary 
intake, eating behavior, physical activity, and psychological health in treatment seeking 
overweight/obese subjects, and secondly to determine the effect of the interaction between these FTO 
polymorphisms as well as haplotype and the mentioned variables on BMI. Please note that we refer to 
the C-allele of the FTO rs1421085 polymorphism and the G-allele of the FTO rs17817449 
polymorphism as the risk alleles, and the T-allele of both polymorphisms as the non-risk alleles as 
previously described in the literature [7,30]. 
2. Experimental Section 
2.1. Study Participants 
The study population consisted of treatment seeking overweight and obese Caucasian subjects  
who were South African citizens and were residing in Cape Town and surrounding areas. In this study 
“Caucasian” refers to individuals of European descent, mainly from Dutch, French, German, and 
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British origin. Subjects were recruited by means of advertisements placed in local newspapers, the e-mail 
bulletins of local universities, and by word of mouth to participate in a weight loss intervention to 
investigate the association between weight loss and genotype. All subjects attended an individual 
recruitment interview with a registered dietitian to provide detailed information regarding the project, 
take anthropometric measurements, and complete a number of questionnaires, including questions on 
the inclusion and exclusion criteria of the study. To be included, subjects had to be between the ages of 
25 and 40 years old with a BMI ≥ 27 kg/m2. Those who were pregnant or breastfeeding, had a history 
of eating disorders, serious psychiatric illnesses or drug or alcohol abuse were excluded. Appointments 
for two follow-up sessions were made during which the rest of the questionnaires were completed and 
a blood sample was taken. A cross-sectional sample of n = 133 overweight/obese subjects was assessed. 
The study was approved by the Health Research Ethics Committee of Stellenbosch University and 
signed informed consent was obtained from all subjects. 
2.2. Genotyping 
Blood was drawn by trained phlebotomists in BD vacutainers with EDTA. A modified protocol by 
Miller et al. [39] was used to extract DNA from the whole blood samples. The polymorphisms were 
genotyped using PCR amplification in a GeneAmp® 2700 PCR System (Applied Biosystems, Foster 
city, CA, USA). The volume of each PCR reaction was 25 μL consisting of 50 ng DNA, 0.2 mM of 
each dNTP (dATP, dCTP, dGTP, dTTP), 10 pmoL of each primer, 2 mM magnesium chloride 
(MgCl2), Taq polymerase and 1× Taq buffer. The following primers, manufactured by Integrated DNA 
Technologies (Leuven, Belgium), were used: 5′-TAGTAGCAGTTCAGGTCCTAAGGCGTG-3′ 
(forward) and 5′-CAGATTAAGGTGATGGGTTG-3′ (reverse) for the FTO rs1421085  
polymorphism (designed using In Silico); 5′-AGGACCTCCTATTTGGGACA-3′ (forward) and  
5′-AGCTTCCATGGCTAGCATTA-3′ (reverse) for the FTO rs17817449 polymorphism [30]. The 
PCR cycles consisted of an initial denaturation at 95 °C for 5 min, followed by 35 cycles of 
denaturation at 95 °C for 30 s, annealing at 55 °C for 45 s and elongation at 72 °C for 30 s. The final 
extension step occurred at 72 °C for 10 min. A mixture of 5 μL of each PCR product and 5 μL cresol 
red loading buffer (2 mg/mL cresol red and 35% (w/v) sucrose) was loaded onto a 1% (w/v) horizontal 
agarose gel (2 g agarose in 200 mL 1× TBE (90 mM Tris-HCl, 90 mM boric acid (H3BO3) and  
0.1 mM EDTA, pH 8.0) and 0.01% ethidium bromide (EtBr)). Electrophoresis was performed at 120 V 
for one hour in 1× TBE buffer solution and then visualized by ultraviolet light transillumination 
(GeneSnap MultiGenius Bio Imaging System, Syngene, Synoptics, Cambridge, UK). A 100 bp ladder 
was also loaded to confirm PCR amplification products of the correct fragment size, i.e., 240 bp (FTO 
rs1421085) and 828 bp (FTO rs17817449). 
Digestion of the PCR products was performed using restriction fragment length polymorphism 
(RFLP) analysis in 20 μL reactions containing 10 μL PCR product, 1× buffer and 1U MaeIII for the 
FTO rs1421085 polymorphism or 2U AlwNI for the FTO rs17817449 polymorphism. The solution was 
incubated at 55 °C (FTO rs1421085) or 37 °C (FTO rs17817449) in a water bath overnight. The 
digested PCR products were loaded onto a 3% agarose gel at 120 V for 1 h (FTO rs1421085) or 1.5% 
Agarose gel at 120 V for 50 min and visualized by ultraviolet light transillumination (GeneSnap 
MultiGenius Bio Imaging System, Syngene). Digestion results for all three genotypes of both 
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polymorphisms were confirmed by Inqaba biotec (Inqaba Biotechnical Industries, Pretoria, South 
Africa) using sequencing analysis, confirming analytical validity. 
2.3. Anthropometry 
Weight and height were measured by trained and standardized fieldworkers and body mass index 
(BMI) was computed as weight (kg)/height (m)2. Weight was measured in light clothing without shoes 
to the nearest 0.1 kg using a calibrated electronic scale with a 250 kg capacity (Physician scale,  
Scales 2000, Durban, South Africa). Height without shoes was measured to the nearest 0.1 cm with a 
stadiometer (Scales 2000, Durban, South Africa). The participants stood with their feet together and 
heels, buttocks, scapulae, and back of the head touching the vertical surface of the stadiometer [40]. 
2.4. Physical Activity 
The validated [41–43] self-administered 16-item Baecke Questionnaire of Habitual Physical 
Activity [44] was used to measure physical activity at work (work index), sport during leisure  
time (sport index), and physical activity during leisure time, excluding sport (leisure-time index). 
Baecke et al. [44] reported good test-retest reliability for the work, sport, and leisure-time indices  
of 0.88, 0.81 and 0.74, respectively. The scores for the three indices were calculated as described by 
Baecke et al. [44]. Higher mean scores for each index reflect higher physical activity levels. 
2.5. Dietary Intake 
The aim of the dietary assessment was to investigate associations between the frequency of intake 
of four indicator food groups and genotype. These food groups were derived from the food list of a 
more comprehensive non-quantified food frequency questionnaire (FFQ) developed for this research. 
Although not validated, this FFQ was derived by a panel of experts from a generic FFQ developed by 
Steyn and Senekal [45] for South Africans, ensuring content and face validity. The four food groups 
included (1) high fat foods (21 items), (2) energy-dense snacks (8 items), (3) energy-dense drinks  
(4 items) and (4) refined bread and cereals (2 items). Frequency of intake of specific food items could 
be indicated as <1/month, 1–3 times/months, 1/week, 2–4/week, 5–6/week, 1/day, 2–3/day,  
4–5/day, 6+/day. For data-analysis the mean daily frequency of intake of each of the four food groups 
was calculated. 
2.6. Eating Behavior 
Eating behavior was assessed with the validated [46,47] self-administered 51-item Three-Factor 
Eating Questionnaire (TFEQ) [48]. Scores for three dimensions (scales) of eating behavior, namely 
dietary restraint, disinhibition and perceived hunger [48] as well as different subscales (summarized  
in Table 1) [49,50] were calculated. Higher scores on scales and subscales reflect higher levels of 
restrained eating, disinhibited eating, and predisposition to hunger [51]. For our sample the Cronbach’s 
alpha was 0.78 for restraint, 0.81 for disinhibition, and 0.78 for perceived hunger, indicating good 
internal reliability. 
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Table 1. Summary, explanation, score range, and reported association with body mass 
index (BMI) of the scales and subscales of the three-factor eating questionnaire. 
Eating Behavior Scale  
or Subscale 
Explanation of Scale or Subscale 
Score 
Range 
Reported/ Expected 
Association with BMI 
Reference 
Dietary restraint 
The extent to which food intake is cognitively 
restricted (by thought and will power) in order 
to control body shape and weight. 
0 to 21 − or + * [48–50] 
Flexible control (consistent 
restraint) 
A more gradual approach towards eating  
and dieting. Foods like sweets and treats  
or fattening foods are eaten but in smaller 
quantities, without feelings of guilt. 
0 to 7 − [49] 
Rigid control (inconsistent 
restraint) 
A dichotomous (all-or-nothing) approach 
towards eating and dieting. All sweets, treats, 
and fattening foods are avoided. 
0 to 7 + [49] 
Strategic dieting behavior Specific behaviors employed to control weight 0 to 4 − or + § [50] 
Attitude to self-regulation (of 
eating) 
Subjects’ general view on dietary intake and 
weight control. 
0 to 5 + [50] 
Avoidance of  
fattening foods 
Deliberate efforts to decrease  
fat content in the diet. 
0 to 4  [50] 
Disinhibition 
The extent of inability to control food intake in 
response to the presence of (1) palatable food 
that may result in the over-consumption of food 
or (2) stimuli such as emotional stress or social 
eating cues that may result in the  
inability to resist food intake when not hungry 
0 to 16 + [48–50] 
Habitual susceptibility  
to disinhibition 
Circumstances predispose to  
recurrent disinhibition 
0 to 5 + [50] 
Emotional susceptibility  
to disinhibition 
Specific negative affective states such as 
emotional stress result in disinhibition 
0 to 3 + [50] 
Situational susceptibility  
to disinhibition 
Specific environmental cues result  
in disinhibition 
0 to 5 + [50] 
Perceived hunger 
The extent of food intake in response to 
susceptibility to general subjective feelings and 
perceptions of hunger and the behavioral 
consequences thereof 
0 to 16 + [48,52] 
Internal locus for hunger 
Type of hunger that is interpreted and  
regulated internally 
0 to 6 + [50] 
External locus for hunger 
Type of hunger that is regulated by  
external cues 
0 to 6 + [50] 
(−) Negative association and (+) positive association. * Conflicting associations have been reported, also reflected in discussion of our 
results. § Negative association for those dissatisfied with their weight; positive association for those satisfied with their weight. 
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2.7. Psychological Health 
The presence and severity of depressive symptoms was assessed with the validated [53,54]  
self-administered 21-item Beck Depression Inventory (BDI) [54]. Scores for each of the 21 items are 
summed to obtain a total score between 0 and 63. Higher scores reflect the presence of more severe 
depressive symptoms [54]. For our sample the Cronbach’s alpha for the BDI was 0.92, indicating 
excellent internal reliability. 
General psychological well-being was assessed with the validated [55–57] self-administered  
30-item General Health Questionnaire (GHQ) [56]. The questionnaire was developed to diagnose possible 
cases of non-psychotic psychiatric disorders and differentiates psychiatric patients as a general class 
from those who consider themselves to be well. A total score between 0 and 30 can be obtained.  
A higher score is indicative of poorer mental health and a greater inability to carry out one’s normal 
‘healthy’ functions [55]. For our sample the Cronbach’s alpha for the GHQ was 0.87, indicating good 
internal reliability. 
Self-esteem was assessed with the validated [58,59] 10-item self-administered Rosenberg  
Self-Esteem Scale (RSES) that was developed by Rosenberg [60] to measure global feelings of  
self-worth or self-acceptance. A total score between 10 and 40 can be obtained. Higher scores reflect  
a higher self-esteem [60]. For our sample the Cronbach’s alpha for the RSES was 0.87, indicating good 
internal reliability. 
2.8. Statistical Analyses 
For descriptive purposes, frequencies were calculated for categorical variables and means and 
standard deviations (Mean ± SD) for numerical variables, as they were found to be normally distributed 
(see Table 2). General linear models were used for all analyses, except for testing Hardy-Weinberg 
Equilibrium (HWE). Unadjusted tests were used for comparing baseline variables, and as significant 
gender differences were detected in a number of variables (results not shown), all further analyses were 
adjusted for gender. 
Genotype distributions were tested for HWE using the exact test. Gender-adjusted linear models 
were used to test the association between lifestyle and psychological health variables and each FTO 
polymorphism using the (1) genotype model (comparing the three genotype groups), (2) dominant 
model (homozygous non-risk genotype vs. risk allele carriers), (3) recessive model (non-risk allele 
carriers vs. homozygous risk genotype) and (4) additive allelic model (counted as zero, one and two 
risk alleles). For these analyses only the significant differences of the best fitting model (smallest  
p-value) are reported in the results section (see Table 3). Effect sizes were calculated to describe each 
significant association. 
Gender-adjusted linear models were also used to determine the effect of the interaction between 
each lifestyle and psychological health variable and (1) the genotype groups (categorized as non-risk, 
heterozygous, and risk genotypes) on BMI; and (2) the additive allelic variable (numerically coded as 
zero, one and two minor alleles) on BMI. In all cases where significant p-values for the effect of the 
interaction between genotype groups with a specific variable on BMI was found, a significant effect 
for the additive allelic variable interaction with the variable was also found. Therefore, to visualize 
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significant results, a plot depicting each of the significant additive allelic interactions with a specified 
variable (x-axes) on BMI (y-axes) was drawn. On all plots, the symbols represent all (male and female) 
individual observed values and the regression lines show the expected relationships for a female for each 
genotype of the polymorphism under investigation. Due to gender adjustment of results, separate plots 
need to be constructed for each gender. As there were more females in the sample, we chose to depict 
regression lines for females to illustrate the results. The expected relationships between the lines would 
be exactly the same for males, their trio of graphs would just start at a different point on the y-axis. 
The plots reflect the modeled rate of change in BMI in response to a change in a specified variable for 
each genotype group. A significant additive allelic interaction indicates that the slopes (e.g., increase in 
BMI corresponding to a one-unit increase/decrease in the lifestyle or psychological health variable) of 
the regression lines of each genotype group differ significantly from each other. A positive interaction 
effect size indicates that the slope of the regression line for the heterozygotes is larger than for subjects 
with no risk alleles, and the slope for the subjects with two risk alleles is even larger. Thus, a negative 
interaction effect size indicates that the slope of the regression line for the heterozygotes is larger than 
of subjects with risk alleles, and the slope for the subjects with no risk alleles is even larger. For each 
plot, the genotype effect sizes reflect the association between BMI and the specified variable for  
each genotype. 
Gender-adjusted linear models were also used to test the association between the FTO  
rs1421085–rs17817449 haplotype and each lifestyle and psychological health variable, as well as  
the effect of the interaction between this haplotype and each lifestyle and psychological health variable 
on BMI. Plots depicting significant additive allelic interactions were drawn. The haplotype analyses 
determine whether a statistical significant difference exists between the slopes of all haplotype groups. 
The slopes that are significantly different from each other on each plot are indicated in the  
results section. 
Data were analyzed using statistical program R [61] and R packages genetics and haplo.stats. All 
results corresponding to a p-value of <0.05 were described as statistically significant. It should be 
noted that multiple comparisons, as performed in this study, are recognized as a common statistical 
approach in genetic association studies [62]. Furthermore, it has been suggested that adjustments, such 
as Bonferroni, are too strict and may result in missing significant associations when performing 
multiple association tests in one group of individuals [63]. Therefore, we did not adjust for multiple 
testing but rather considered the results of all association tests while interpreting each significant p-value 
with caution, taking into account the plausibility of the finding as recommended by Perneger [64]. 
Some results may thus be considered hypotheses generating, whereas the replication of previously 
reported results and functional explanation of the association between the polymorphism and phenotype 
may verify plausibility of such results [62]. 
3. Results 
3.1. Socio-Demographic and Weight Profile of the Cross-Sectional Sample 
The subjects had a mean ± SD age of 32.9 ± 4.4 years, weight of 99.9 ± 20.1 kg, height of  
1.68 ± 0.08 m and BMI of 35.2 ± 6.6 kg/m2. In this sample 21.8% of subjects were overweight  
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(BMI of 27–29.9 kg/m2), 33.1% were obese class I (BMI of 30–34.9 kg/m2), 24.1% were obese class II  
(BMI of 35–39.9 kg/m2) and 21.0% were obese class III (BMI ≥ 40 kg/m2). Most were female, 
married, Afrikaans speaking, had a tertiary qualification, and lived with their partners and children  
(Table 2). There were no significant differences in mean BMI between the response categories of the  
socio-demographic variables. 
Table 2. Socio-demographic profile and genotype, allele and haplotype frequencies of the 
FTO rs1421085 and rs17817449 polymorphisms. 
Socio-Demographic Variables and Polymorphisms n % 
BMI (kg/m2)  
Mean ± SD 
p-Value 
Gender     
Female 112 84.2 35.3 ± 6.9 0.818 
Male 21 15.8 34.9 ± 4.5  
Marital status     
Married/living together 86 64.7 35.1 ± 6.3 0.703 
Unmarried (including separated/divorced) 47 35.3 35.5 ± 7.1  
Home language     
Afrikaans 120 90.2 35.2 ± 6.5 0.729 
English 13 9.8 35.8 ± 7.2  
Level of education     
Completed Grade 10 or Matric 43 32.3 35.1 ± 7.3 0.887 
Tertiary qualification 90 67.7 35.3 ± 6.2  
Living     
alone 22 16.5 37.4 ± 8.0 0.156 
with friends/parents 20 15.0 33.7 ± 6.0  
with a partner 30 22.6 33.8 ± 5.6  
with a partner and child (ren) 61 45.9 35.7 ± 6.5  
FTO rs1421085 polymorphism     
Genotype frequencies: TT 21 20.8 34.5 ± 7.3 0.1566 
TC 55 54.5 36.6 ± 7.0  
CC 25 24.7 33.6 ± 5.4  
Allele frequencies: Risk allele: C  52.0  0.5831 
FTO rs17817449 polymorphism     
Genotype frequencies: TT 31 29.5 35.9 ± 7.0 0.7814 
TG 32 30.5 34.9 ± 6.8  
GG 42 40.0 36.0 ± 7.2  
Allele frequencies: Risk allele: G  55.2  0.9178 
FTO rs1421085-rs17817449 haplotype frequencies     
Haplotypes: C-G * 27.3 * 0.6010 
C-T  24.7   
T-G  27.9   
T-T  20.0   
* Where haplotype allocation was uncertain (i.e., when a subject is heterozygous T-C and T-G for both polymorphisms, it 
cannot be established whether the haplotype for the individual is for example T-T or C-G), different pairs of haplotypes, 
with probabilities of being the true haplotype were inferred for individuals and thus cannot be counted. 
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3.2. Genotype and Allele Frequencies 
The frequencies of the homozygous GG genotype (n = 42, 40.0%) of the FTO rs17817449 
polymorphism and the heterozygous TC genotype of the FTO rs1421085 polymorphism were the most 
prevalent (Table 2). The frequencies of the risk alleles of both FTO polymorphisms were higher than 
the respective non-risk T-alleles. The genotype frequencies of the FTO rs1421085 polymorphism  
were in HWE (p = 0.4284), while the genotype frequencies of the FTO rs17817449 polymorphisms  
were not in HWE (p = 0.0001). The frequency of the non-risk T-T haplotype of the FTO  
rs1421085–rs17817449 haplotype was the lowest in this sample (Table 2). No associations between 
BMI and genotype groups, additive allelic scores or haplotypes were found. 
3.3. Dietary Intake of Indicator Food Groups 
Subjects with the homozygous GG genotype of the FTO rs17817449 polymorphism had a  
1.74 and 0.67 times higher intake of high-fat foods and refined starches, respectively, than subjects 
with one or no risk alleles (Table 3). No significant associations were found between the FTO 
polymorphisms and energy dense snacks or drinks consumed. 
Table 3. Significant associations between genotype groups of FTO rs1421085 and 
rs17817449 polymorphisms and lifestyle/psychological health variables. 
Lifestyle/Psychological 
Health Variable 
Polymorphisms Genotypes n * Mean ± SD 
Effect  
Size ± SE 
Model p-Value
Food groups    
Frequency of 
intake/day 
   
High fat foods FTO rs17817449 
T-allele carriers 
GG 
59 
38 
4.9 ± 3.6 
6.6 ± 4.9 
1.74 ± 0.87 Recessive G 0.0494 
Refined starches FTO rs17817449 
T-allele carriers 
GG 
59 
38 
0.94 ± 1.36 
1.59 ± 1.55 
0.67 ± 0.30 Recessive G 0.0287 
TFEQ    
Questionnaire 
score 
   
Perceived hunger FTO rs1421085 
TT 
TC 
CC 
20 
54 
23 
5.9 ± 3.4 
7.3 ± 3.0 
8.8 ± 3.9 
1.43 ± 0.52 Additive C 0.0072 
Hunger:  
Internal locus of control 
FTO rs1421085 
TT 
TC 
CC 
20 
54 
23 
2.2 ± 1.7 
2.8 ± 1.8 
3.9 ± 2.0 
0.84 ± 0.28 Additive C 0.0038 
Emotional disinhibition FTO rs1421085 
TT 
C-allele carriers 
20 
77 
2.0 ± 1.3 
2.4 ± 1.1 
0.58 ± 0.26 Dominant C 0.0281 
Restraint scale:  
Flexible control 
FTO rs1421085 
TT 
C-allele carriers 
20 
77 
1.7 ± 1.6 
2.5 ± 1.7 
0.89 ± 0.43 Dominant C 0.0392 
BDI FTO rs17817449 
T-allele carriers 
GG 
61 
40 
12.7 ± 9.4 
17.6 ± 10.7 
4.58 ± 2.02 Recessive G 0.0256 
BDI = Beck depression inventory, RSES = Rosenberg self-esteem scale. * n vary due to missing values. Risk allele for  
FTO rs1421085 = C-allele and for FTO rs17817449 = G-allele. Non-significant differences not included in table. 
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3.4. Eating Behavior 
The association between the FTO rs1421085 polymorphism and perceived hunger was significant 
for the recessive, dominant, genotype, and additive allelic models, with the latter being the best fit.  
It was found that the perceived hunger score of subjects with one risk allele was 1.43 times higher than 
the score of subjects with no risk alleles, while those with two risk alleles had a 2.86 times higher score 
(Table 3). Similarly, subjects with two risk alleles of the FTO rs1421085 polymorphism had the highest 
internal locus of control for hunger scores compared to those with one or no C-alleles. Furthermore, 
the risk C-allele carriers also had higher emotional disinhibition and flexible control scores compared 
to the TT homozygotes (Table 3). 
The rate of change in BMI in response to a change in the rigid control (allelic effect size =1.67,  
p = 0.0290, Figure 1a) and self-regulation (allelic effect size = 2.29, p = 0.0095, Figure 1b) subscale 
scores differed significantly between the genotype groups of the FTO rs1421085 polymorphism. The 
addition of one risk C-allele results in a 1.67-unit or 2.29-unit increase in the slope (rate of change) of 
BMI for each one-unit increase in the rigid control (Figure 1a) or self-regulation (Figure 1b) score, 
respectively, when compared to subjects with no risk alleles. Therefore, the addition of two risk alleles 
would result in a 3.34-unit or 4.58-unit increase in the slope of BMI for each one-unit increase in the 
rigid control or self-regulation scores, respectively. The most pronounced decrease in BMI in response 
to an increase in the rigid control (genotype effect size = −2.37, p = 0.0078 for the TT regression line 
on Figure 1a) or attitude to self-regulation scores (genotype effect size = −3.11; p = 0.0078 for the  
TT regression line on Figure 1a) was observed for the non-risk TT homozygotes. Thus, each one-unit 
increase in the rigid control or self-regulation score of TT homozygotes results in a 2.37-unit or  
3.11-unit decrease in BMI, respectively. The unit change in BMI in response to an increase in the rigid 
control score of the CT (−2.37 + 1.67 = −0.70 unit) and CC (−2.37 + 3.34 = 0.97 unit) genotypes was 
smaller than the TT homozygotes and non-significant. Similarly, smaller non-significant changes in 
BMI in response to an increase in the self-regulation score (CT: −3.11 plus 2.29 = −0.82 unit and  
CC: −3.11 plus 4.58 = 1.47 unit) were found. 
Haplotype analyses revealed that the rate of change in BMI in response to a change in the dietary 
restraint (effect size = 0.74, SE = 0.35, p = 0.0389, Figure 2a) and self-regulation (effect size = 2.7,  
SE = 1.21, p = 0.0273, Figure 2b) scores differed significantly between the T-T and C-T haplotypes  
of the two FTO polymorphisms. Although it is evident from Figure 2a,b that an increase in  
dietary restraint or attitude to self-regulation was associated with a decrease in BMI for each T-T 
haplotype and an increase in BMI for each C-T haplotype, these individual associations were not 
statistically significant. 
The rate of change in BMI in response to a change in rigid control differed significantly between 
the T-T and C-T (effect size = 2.25, SE = 0.95, p = 0.0190) as well as the T-T and C-G (effect  
size = 2.31, SE = 1.03, p = 0.0268) haplotypes of the two FTO polymorphisms (Figure 2c). For each 
T-T haplotype, a one-unit increase in the rigid control score results in a decrease in BMI of  
1.79 kg/m2 (effect size = 1.79, p = 0.010). The change in BMI in response to a change in the rigid 
control score was not significant for any of the other haplotypes. 
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Figure 1. Interactions between the FTO rs1421085 polymorphism and eating behavior  
or psychological health on BMI. Plots of BMI against (a) rigid control score (p = 0.0290);  
(b) attitude to self-regulation score (p = 0.0095) and (c) General Health Questionnaire 
score (p = 0.0085). Symbols represent all individual observed values for males and females 
and regression lines show the expected relationships for a female, from the additive allelic 
model, for each genotype of the FTO rs1421085 polymorphism. 
 
3.5. Physical Activity 
No associations were found between the FTO rs1421085 or rs17817449 polymorphisms  
and physical activity levels (results not reported). However, the rate of change in BMI in response to  
a change in the sports index score differed significantly between the T-T and C-T (effect size = 4.57,  
SE = 1.95, p = 0.0212) as well as between the T-T and T-G (effect size = 3.53, SE = 1.75, p = 0.0469) 
haplotypes of the two FTO polymorphisms (Figure 2d). For each T-T haplotype, a one-unit increase  
in the sport index score results in a decrease in BMI of 3.87 kg/m2 (effect size = 3.87, p = 0.004). The 
change in BMI in response to a change in the sport index score was not significant for any of the  
other haplotypes. 
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Figure 2. Interactions between the fat mass and obesity-associated (FTO) rs1421085-
rs17817449 haplotype and eating behavior or physical activity on BMI. Plots of BMI 
against (a) dietary restraint; (b) self-regulation; (c) rigid control and (d) sport index scores. 
Regression lines show the expected relationships, for a woman, from the additive 
haplotype model, for each FTO rs1421085-rs17817449 haplotype. 
 
3.6. Psychological Health 
No associations were found between the genotypes of the FTO polymorphisms and the RSES  
or GHQ scores. Significantly higher BDI scores were found in the GG homozygotes of the FTO 
rs17817449 polymorphism (Table 3). 
The rate of change in BMI in response to a change in the GHQ score differed significantly between 
the genotype groups of the FTO rs1421085 polymorphism (allelic effect size = −0.53, p = 0.0085, 
Figure 1c). The addition of one risk C-allele results in a 0.53-unit decrease in the slope of BMI for 
each one-unit increase in the GHQ score when compared to TT homozygotes with no risk alleles. 
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Therefore, the addition of two risk alleles would result in a 1.06-unit decrease in the slope of BMI  
for each one-unit increase in the GHQ score. The most pronounced increase in BMI in response to an 
increase in GHQ score was observed for the non-risk TT homozygotes (genotype effect size = 0.78,  
p = 0.0026). Thus, each one-unit increase in the GHQ score of TT homozygotes results in a 0.78-unit 
increase in BMI. The unit change in BMI in response to an increase in the GHQ scores of the  
CT (0.78 − 0.53 = 0.25 unit) and CC (0.78 − 1.06 = −0.28 unit) genotypes was smaller than the TT 
homozygotes and non-significant. 
4. Discussion 
The main findings of this study show associations between the FTO rs1421085 and rs17817449 
polymorphisms and indicators of eating behavior, dietary intake, physical activity, and psychological 
health. Furthermore, our findings show that the interactions between these variables and the FTO 
polymorphisms may be associated with the BMI of overweight/obese Caucasian adults. These results 
support the proposed involvement of FTO polymorphisms in regulation of energy homeostasis [32,36]. 
Our results indicate that subjects with the risk GG genotype of the FTO rs17817449 polymorphism 
had a higher intake of high fat foods and refined starches. Furthermore, subjects with the risk C-allele 
of the FTO rs1421085 polymorphism were characterized by a higher perceived hunger score, which 
reflects a higher susceptibility to general subjective feelings and perceptions of hunger that may result 
in higher food intake [48]. Subscale analysis of the hunger score revealed that the perceived hunger of 
C-allele carriers was internally interpreted and regulated (higher internal locus for hunger score). This 
implies that these subjects perceived themselves to be hungry more often and finding themselves “just 
having to eat something at any time”, thus possibly resulting in eating more frequently during the  
day [50]. The C-allele carriers were also characterized by a higher emotional disinhibition score,  
which reflects disinhibition that arises as a result of emotional feelings such as loneliness, anxiousness 
or feeling depressed [50]. These significant associations from our study point to the possibility  
that subjects with one or more risk alleles of the FTO rs1421085 or rs17817449 polymorphisms may  
have poorer eating behaviors and a higher intake of high fat foods or refined starches. However, it 
must be noted that the fact that C-allele carriers had a higher flexible control score (subscale score of 
dietary restraint), may not support this notion. A higher flexible control score reflects better eating 
behavior, namely the occasional intake of sweets, treats, and high fat foods, but in limited amounts. 
This approach reflects a more consistent restraint that is conducive to effective weight  
management strategies [49]. 
To our knowledge this is the first study to report on the associations between the FTO rs1421085 or 
rs17817449 polymorphisms and TFEQ subscales. This is also the first study to report on the FTO 
rs17817449 polymorphism and food intake, as well as the TFEQ scales. In the only publication that 
could be traced that investigated the associations between the FTO rs1421085 polymorphism and the 
TFEQ scales, snacking or eating large quantities of food, no associations were found [38]. This is in 
contrast to the association we find between this polymorphism and perceived hunger. It can be argued 
that our results are in line with those of McCaffery et al. [37], who reported a higher daily intake of 
energy, percentage fat contribution to total energy, number of meals and snacks, as well as servings of 
fats, oils, and sweets by the risk allele carriers of the FTO rs1421085 polymorphism. Furthermore, 
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support for possible associations between dietary intake and eating behaviors and the FTO gene comes 
from research on polymorphisms located in the same LD block as the rs1421085 and rs17817449 
polymorphisms. In children, the high risk genotype or allele of the FTO rs9939609 polymorphism was 
associated with impaired ability to respond to satiety cues [65], a higher intake of highly palatable 
foods [36], a higher energy intake [29], more frequent “loss of control” eating episodes, and a higher 
intake of high fat foods at a lunch buffet [35]. However, some studies were unable to replicate these 
results in children or adolescents [33,66]. In Caucasian adults, a greater number of meals and snacks 
per day [37] and a higher energy intake from fat [67] and a higher energy intake were associated with 
the risk alleles of the FTO rs9939609 [32] and rs8050136 polymorphisms [34]. Most of the evidence at 
this stage thus seems to support our findings that the risk allele carriers of the FTO polymorphisms 
may have poorer eating behaviors. It could thus be argued that our finding that the risk genotype has 
higher flexible control is possibly a false positive. 
Our modeling results illustrate that interactions between FTO genotypes or haplotypes investigated 
in this study and eating behavior may be associated with the BMI of subjects. For instance, the results 
indicate that subjects with the non-risk TT genotype of the FTO rs1421085 polymorphism may benefit 
from improving their attitude to self-regulation score (subscale score of dietary restraint) when 
attempting weight reduction, while the same beneficial effect may not be experienced by the risk allele 
carriers. It was evident that an increase in the self-regulation score of one-unit was associated with  
a significant 3.11 kg/m2 decrease in BMI. An increase in attitude to self-regulation score denotes 
increased dietary restraint and reflects a subject’s general view on eating and the importance of dieting, 
more specifically consideration of the energy content of food and eating specific foods at specific 
times for weight control [50]. Conflicting results regarding the association between dietary restraint 
and BMI have been reported. However, the potential benefit from increasing dietary restraint during 
weight reduction is supported by the fact that a lower restraint score has been associated with higher 
body weight [68,69] and that decreases in dietary restraint over time were associated with concurrent 
weight gain [70]. Furthermore, an increase in dietary restraint during weight loss was associated with a 
greater weight loss [49,71] and was found to be a significant predictor of weight maintenance over  
two years [72]. It is thus not surprising that Hill et al. [73] argue in a review article that chronic dietary 
restraint is necessary to be an effective weight manager in the current obesogenic environment. Our 
subscale analysis of dietary restraint further indicates that a modeled increase in the rigid control score 
was associated with the most pronounced decrease in BMI of subjects with the non-risk TT genotype 
of the FTO rs1421085 polymorphism and a significant decrease in the BMI of subjects with a T-T 
haplotype. Rigid control specifically relates to the complete avoidance of “fattening foods”, sweets 
and/or treats, with individuals employing an all-or-nothing approach to dieting. Over the short-term,  
a high rigid control may be associated with decreases in BMI, which may explain our results. 
However, high rigid control is not recommended for effective weight management purposes, as 
frequent lapses or total relapse may occur, which explains the higher BMIs, energy intakes, and less 
success with weight loss in individuals with a higher rigid control [49,74]. It should be noted that  
the other significant interactions found between the FTO haplotype, BMI, and dietary restraint, as  
well as attitude to self-regulation scores, cannot be further interpreted as no individual haplotype was 
significantly associated with BMI and eating behavior changes. 
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A role for FTO in the regulation of energy expenditure has also been proposed and investigated. 
Although no studies could be traced that investigated the association between physical activity  
and the FTO rs1421085 or rs17817449 polymorphisms, the association with the FTO rs9939609 
polymorphism has been examined. Some studies have failed to show any association with indicators of 
physical activity levels and energy expenditure [31–33,36,66]. This is in line with our results that show 
no association between the genotype groups of the FTO rs1421085 or rs17817449 polymorphisms and 
self-reported physical activity levels at work, during leisure-time or sport. In contrast, an association 
between the risk alleles of the FTO rs9939609 polymorphism and increased energy expenditure has 
been reported by Cecil et al. [29] and Do et al. [30]. The possibility of an association between BMI, 
the FTO gene, and physical activity levels is also supported by the results from a meta-analysis 
indicating that adults who were physically inactive and carriers of the risk allele of the FTO rs9939609 
polymorphism had a higher obesity risk than their physically active counterparts [75]. In line with the 
latter results, our haplotype analysis indicates that each one-unit increase in physical activity levels 
(sport index) was associated with a significant 3.87 kg/m2 decrease in BMI for each non-risk T-T 
haplotype. This implies that subjects with no risk alleles of the two FTO polymorphisms may benefit 
the most from increasing their physical activity levels when attempting weight loss. In practical terms, 
a one-unit increase in the sport index score of a physically inactive subject can easily be achieved by 
practicing a low-level activity such as walking for 1–2 h per week. Subjects who already walk 1–2 h 
per week should increase this to 3–4 h per week and additionally practice a medium level activity such 
as swimming, jogging, aerobics or cycling for at least one hour per week. Instead, walking time can 
also be fully substituted for these medium level activities (3–4 h per week) to achieve the one-unit 
increase in sport index score (all recommendations were calculated using the equations for calculating 
the sport index score by Baecke et al. [44]). 
It is known that various mental and personality disorders such as mania, anxiety, and depression 
contribute to the hedonic aspects of overeating and may predict the development of obesity [76,77]. As 
FTO is expressed throughout the brain it may be associated with psychological behaviors such as 
depression or psychological distress and consequent BMI of individuals. Although no reports could be 
traced on the association between psychological well-being and the FTO rs1421085 or rs17817449 
polymorphisms, associations with other FTO polymorphisms have recently been investigated [78,79]. 
For instance, associations between BMI, depression, and 10 polymorphisms in the FTO gene have 
been reported by Rivera et al. [78]. We also found a significant association between the FTO 
rs1421085 polymorphism, BMI, and general psychological well-being. It was specifically found that 
each one-unit increase in GHQ-score was associated with the most pronounced 0.78 kg/m2 increase in 
the BMI of the non-risk TT subjects of the FTO rs1421085 polymorphism. The GHQ score is 
calculated from 30 questions and each question may contribute one-unit to the total score if the answer 
reflects the psychological distress option. Therefore, worsening of general psychological well-being 
may readily result in a few units increase in the GHQ score and consequently a significant increase in 
BMI. Our results further suggest that the at-risk GG subjects of the FTO rs17817449 polymorphism  
may experience more depressive symptoms (as measured by the BDI). In contrast to our results, 
Samaan et al. [79] reported that the risk A-allele of FTO rs9939609 was associated with a lower risk of 
depression [79]. As a limited number of reports have investigated these associations, more research is 
clearly necessary to understand the association between psychological health, BMI, and the FTO gene. 
Nutrients 2014, 6 3146 
 
 
This study is limited by the fact that most variables were self-reported, including physical activity, 
dietary intake, eating behavior, and psychological health, which may not necessarily reflect the truth. 
We aimed to improve the validity of these outcome measures by using instruments validated in similar 
populations and checking the internal consistency reliability. Although content and face validity of the 
food lists included in the FFQ were ensured, validation of the daily frequency of intake of items in the 
four indicator food groups against another method, e.g., food records, is recommended. It is important 
to note that the results of this study pertain to overweight/obese individuals only. This is reflected  
by the genotype and allele frequencies of the two polymorphisms investigated in this sample, which 
were in line with those previously reported for obese Caucasian populations [7,80,81]. Although the 
sample did not include normal weight participants, the BMI range of included participants (27.0 kg/m2 
to 57.6 kg/m2) supported the potential for investigation of associations between BMI, genotype  
and lifestyle, eating behavior and psychological variables. The deviation found in HWE for the FTO 
rs17817449 polymorphism also needs to be considered in the interpretation of the results for this 
polymorphism. As genotyping errors can be excluded, we suggest that the fact that the sample is not 
representative of a general population (did not include subjects with a BMI < 27) could explain the 
HWE finding. As most obesity related polymorphisms are expected to have a small effect on obesity 
development or weight loss outcomes, the sample size restricted statistical power of analyses. This 
may have resulted in non-detection of possible associations. 
5. Conclusions 
The risk alleles of the FTO rs1421085 and rs17817449 polymorphisms may be associated with 
poorer eating behaviors (reflected by higher hunger, internal locus for hunger, and emotional 
disinhibition scores), a higher intake of high fat foods and refined starches and more depressive 
symptoms in treatment seeking overweight/obese Caucasian adults. Furthermore, our modeled results 
indicate that the interactions between the FTO polymorphisms or haplotypes and eating behavior, 
psychological health and physical activity levels may be associated with BMI. A higher rigid control 
and attitude to self-regulation score may decrease the BMI of the non-risk homozygotes of FTO 
rs1421085, while an increase in psychological distress (increased GHQ score) may increase their BMI. 
Furthermore, increased sport participation may result in a lower BMI in subjects with the non-risk 
haplotype. These results may explain current findings that the risk alleles of both FTO polymorphisms 
have consistently been associated with a higher BMI or obesity prevalence [7,9,30,38,80,81].  
We recommend that the novel associations found in the current study should be viewed as “hypotheses 
generating” and that they should be replicated and further investigated to establish the clinical 
significance for implementation as part of weight management interventions. 
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